Merck

EU Regulators Endorse Expanded Use Of Merck's WINREVAIR In Adult PAH Patients

EU Regulators Endorse Expanded Use Of Merck's WINREVAIR In Adult PAH Patients

20 hours ago

2 min read

Merck Announces Strong Phase 3 CORALreef HeFH Results for Investigational Oral PCSK9 Inhibitor Enlicitide

Merck Announces Strong Phase 3 CORALreef HeFH Results for Investigational Oral PCSK9 Inhibitor Enlicitide

11 Nov 2025

2 min read

Merck Secures $700 Million from Blackstone to Advance Development of TROP2-Targeting ADC, Sacituzumab Tirumotecan

Precision Medicine

Merck Secures $700 Million from Blackstone to Advance Development of TROP2-Targeting ADC, Sacituzumab Tirumotecan

05 Nov 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com